Camille is funded by a grant FRM “Retour en France”. Her project focuses on gut associated archaeal mehanogens and Negativicutes and their impact on the innate immune system and intestinal physiology.
Click to view graph
Connections
Click to view timeline
Timeline
Projects
CV
Experience
- 2021
Postdoctoral fellow
Institut Pasteur (EBMC Unit)
- 2016
Postdoctoral fellow (2.5 years)
ESB group, LCSB, University of Luxembourg, Luxembourg – Paul Wilmes’ Laboratory
- Interaction of Fusobacterium nucleatum extracellular vesicles with the gut epithelial cells innate immunity
- Gut microbiome multi-omics profile as a predictive marker of SARS-CoV-2 disease severity
Education
-
2016
Ph.D. in Biology, Sorbonne University (Paris) – MICALIS INRA (Jouy-en-Josas) – Supervisor Dr N. Lapaque
Impact of the gut microbiota on the immuno-modulatory functions of the intestinal epithelial humans cells
-
2014
Master Degree in Biology and Health, University of Versailles-St-Quentin, France
Impact of bacterial microbiota on anti-inflammatory genes TGF-b1 and IDO-1 in human colonocytes,at MICALIS, INRA (Jouy-en-Josas)
-
2007
Master Degree in Contemporary History, University of Paris 1 Sorbonne, France
Publications
- C. Martin-Gallausiaux, A. Malabirade, J. Habier, P. Wilmes (2020), Fusobacterium nucleatum extracellular vesicles modulate gut epithelial cells innate immunity via FomA and TLR2, Frontiers in Immunology, doi.org/10.3389/fimmu.2020.583644
- C. Martin-Gallausiaux, L. Marinelli, H. M. Blottière, P. Larraufie and N. Lapaque, SCFA: mechanisms and functional importance in the gut (2020), Proc of the Nutrition Society, doi.org/10.1017/S0029665120006916.
- C. Benakis1, C. Martin-Gallausiaux, J-P. Trezzi, P. Melton1, A. Liesz and P Wilmes (2019). Wilmes, The microbiome-gut-brain axis in acute and chronic brain diseases, Current Opinion in Neurobiology, Vol 61, doi.org/10.1016/j.conb.2019.11.009.
- L. Marinelli, C. Martin-Gallausiaux, J-M Bourhis, F. Béguet-Crespel, H. M. Blottière and N. Lapaque, (2019), Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cells, Scientific Reports, 9, 943, doi.org/10.1038/s41598-018-37019-2
- C. Martin-Gallausiaux, F. Béguet-Crespel, L. Marinelli, A. Jamet, F. Ledue, H. M. Blottière and N. Lapaque, (2018), Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells, Scientific Reports, 8, doi.org/10.1038/s41598-018-28048-y
- C. Martin-Gallausiaux, P. Larraufie, A. Jarry, F. Béguet-Crespel, L. Marinelli, F. Ledue, F. Reimann, H.M. Blottière and N. Lapaque, (2018), Butyrate produced by commensal bacteria down-regulates indolamine 2, 3-dioxygenase 1 (IDO-1) expression via a dual mechanism in human intestinal epithelial cells, Frontiers in Immunology, 9, 2838, doi.org/ 10.3389/fimmu.2018.02838
- Larraufie, P. F., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., & Blottiere, H. (2018). SCFAs strongly stimulate PYY production in human enteroendocrine cells. Scientific reports, 8 (1), 74. doi.org/10.1038/s41598-017-18259-0
- Hoffmann TW, Pham HP, Bridonneau C, Aubry C, Lamas B, Martin-Gallausiaux C, Moroldo M, Rainteau D, Lapaque N, Six A, Richard ML, Fargier E, Le Guern ME, Langella P, Sokol H. (2016) Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J; 10(2): 460-77. doi.org/10.1038/ismej.2015.127.